Cite
HARVARD Citation
Lichtenegger, F. et al. (2020). Toll‐like receptor 7/8‐matured RNA‐transduced dendritic cells as post‐remission therapy in acute myeloid leukaemia: results of a phase I trial. Clinical & translational immunology. 9 (3), p. n/a. [Online].